• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典南部 Mohs 队列研究中复杂型 Mohs 手术的风险因素。

Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort.

机构信息

Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

Department of Clinical Sciences, Helsingborg Hospital, Helsingborg, Sweden.

出版信息

J Eur Acad Dermatol Venereol. 2022 Jul;36(7):1113-1117. doi: 10.1111/jdv.18124. Epub 2022 Apr 12.

DOI:10.1111/jdv.18124
PMID:35366359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9324151/
Abstract

BACKGROUND

Mohs micrographic surgery (MMS) is a precise, tissue-sparing surgical technique that offers superior cure rates compared to traditional surgical excision. However, the degree of difficulty of MMS depends on many variables, and consequently, the number of surgical stages required for each case is quite unpredictable.

OBJECTIVES

To identify risk factors for complicated MMS, defined as MMS requiring ≥3 stages.

METHODS

In a cohort study design, data were prospectively collected from 612 patients that underwent MMS for basal cell carcinoma (BCC) at the Department of Dermatology, Skåne University Hospital, Lund, between 2009 and 2020. Univariate and multivariate logistic regression were used to estimate the risk of MMS requiring ≥3 stages. Due to the risk of multicollinearity between recurrent or incompletely excised BCC and previous treatments, a partially and a fully adjusted multivariate logistic regression model were constructed.

RESULTS

In fully adjusted multivariate analyses, age (odds ratio (OR) 1.02; confidence interval (CI) 95% 1.00-1.04), previous cryotherapy (OR 2.3; CI 95% 1.1-4.8), and >1 previous surgery (OR 3.4; CI 95% 1.5-7.7) were significantly associated with risk of complicated MMS. Recurrent BCC was associated with the risk of complicated MMS in partially adjusted multivariate analyses, but not in the fully adjusted analyses. In this highly selected cohort, histopathological subtype, and tumour localization were not associated with the risk of complicated MMS.

CONCLUSIONS

Older age and tumours previously treated with cryotherapy or multiple prior surgeries increased the risk of MMS requiring ≥3 stages. Whether recurrent BCC is an independent risk factor for complicated MMS needs further evaluation. Knowledge of these risk factors may ameliorate the planning of Mohs surgeries.

摘要

背景

Mohs 显微外科手术(MMS)是一种精确的、保留组织的手术技术,与传统的手术切除相比,具有更高的治愈率。然而,MMS 的难度取决于许多变量,因此,每个病例所需的手术阶段数量是非常不可预测的。

目的

确定 MMS 复杂的危险因素,定义为需要≥3 个阶段的 MMS。

方法

在一项队列研究设计中,数据从 2009 年至 2020 年在隆德的斯科讷大学医院皮肤科接受 MMS 治疗基底细胞癌(BCC)的 612 名患者中前瞻性收集。使用单变量和多变量逻辑回归来估计需要≥3 个阶段的 MMS 风险。由于复发性或不完全切除的 BCC 和先前治疗之间存在多线性风险,因此构建了部分和完全调整的多变量逻辑回归模型。

结果

在完全调整的多变量分析中,年龄(比值比(OR)1.02;95%置信区间(CI)1.00-1.04)、先前的冷冻疗法(OR 2.3;CI 95% 1.1-4.8)和>1 次先前手术(OR 3.4;CI 95% 1.5-7.7)与 MMS 复杂的风险显著相关。复发性 BCC 与部分调整的多变量分析中的 MMS 复杂风险相关,但与完全调整的分析无关。在这个高度选择的队列中,组织病理学亚型和肿瘤定位与 MMS 复杂的风险无关。

结论

年龄较大和先前用冷冻疗法或多次先前手术治疗的肿瘤增加了需要≥3 个阶段的 MMS 的风险。复发性 BCC 是否是 MMS 复杂的独立危险因素需要进一步评估。了解这些危险因素可能会改善 Mohs 手术的规划。

相似文献

1
Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort.瑞典南部 Mohs 队列研究中复杂型 Mohs 手术的风险因素。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):1113-1117. doi: 10.1111/jdv.18124. Epub 2022 Apr 12.
2
Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.Mohs 显微外科手术治疗头颈部基底细胞癌的低复发率:1021 例回顾性研究。
Clin Otolaryngol. 2018 Oct;43(5):1321-1327. doi: 10.1111/coa.13176. Epub 2018 Jul 19.
3
Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.面对高负担皮肤癌时,某单中心基底细胞癌莫氏手术的合理使用标准:一项回顾性队列研究。
J Dermatolog Treat. 2019 Feb;30(1):74-80. doi: 10.1080/09546634.2018.1468868. Epub 2018 May 10.
4
Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.影响基底细胞癌 Mohs 手术分期数的临床病理因素。
An Bras Dermatol. 2022 May-Jun;97(3):291-297. doi: 10.1016/j.abd.2021.08.007. Epub 2022 Apr 2.
5
Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.基底细胞癌的莫氏显微外科手术:一项西班牙回顾性研究结果及肿瘤复发的Kaplan-Meier生存分析
J Eur Acad Dermatol Venereol. 2014 Oct;28(10):1363-9. doi: 10.1111/jdv.12293.
6
Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.莫氏显微外科手术治疗面部基底细胞癌——一项回顾性研究结果及文献综述
Br J Dermatol. 2004 Jul;151(1):141-7. doi: 10.1111/j.1365-2133.2004.06047.x.
7
Previous therapy and the recurrence rate of basal cell carcinoma after Mohs surgery: a meta-analysis.既往治疗与 Mohs 手术后基底细胞癌的复发率:一项荟萃分析。
Arch Dermatol Res. 2023 Aug;315(6):1747-1754. doi: 10.1007/s00403-023-02558-w. Epub 2023 Feb 27.
8
Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.基底细胞癌亚型与 Mohs 显微外科术中组织学证实的亚临床扩展的相关性:一项前瞻性多中心研究。
J Am Acad Dermatol. 2022 Jun;86(6):1309-1317. doi: 10.1016/j.jaad.2022.02.037. Epub 2022 Feb 26.
9
Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.手术切除与莫氏显微描记手术治疗面部原发性和复发性基底细胞癌的比较:一项为期5年随访的前瞻性随机对照试验。
Lancet Oncol. 2008 Dec;9(12):1149-56. doi: 10.1016/S1470-2045(08)70260-2. Epub 2008 Nov 17.
10
Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.莫氏显微外科手术与手术切除治疗面部基底细胞癌的成本效益分析
Arch Dermatol. 2006 Feb;142(2):187-94. doi: 10.1001/archderm.142.2.187.

引用本文的文献

1
Features associated with the use of single or combined reconstructions: analysis of 1,124 Mohs surgeries.与使用单一或联合重建相关的特征:对1124例莫氏手术的分析
An Bras Dermatol. 2025 Mar-Apr;100(2):342-345. doi: 10.1016/j.abd.2024.07.009. Epub 2025 Jan 31.

本文引用的文献

1
Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study.瑞典基底细胞癌的发病率和趋势:一项基于人群的登记研究。
Br J Dermatol. 2022 Jun;186(6):963-969. doi: 10.1111/bjd.20964. Epub 2022 Apr 3.
2
Interventions for basal cell carcinoma of the skin.皮肤基底细胞癌的干预措施。
Cochrane Database Syst Rev. 2020 Nov 17;11(11):CD003412. doi: 10.1002/14651858.CD003412.pub3.
3
Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.利用医师计费数据估算萨斯喀彻温省的非黑色素瘤皮肤癌的医疗保健费用。
Curr Oncol. 2019 Apr;26(2):114-118. doi: 10.3747/co.26.4557. Epub 2019 Apr 1.
4
Patient Indications for Mohs Micrographic Surgery: A Systematic Review.莫氏显微外科手术的患者适应症:一项系统评价。
J Cutan Med Surg. 2019 Jan/Feb;23(1):75-90. doi: 10.1177/1203475418786208. Epub 2018 Jul 22.
5
Mohs Micrographic Surgery: Development, Technique, and Applications in Cutaneous Malignancies.莫氏显微外科手术:皮肤恶性肿瘤的发展、技术及应用
Semin Plast Surg. 2018 May;32(2):60-68. doi: 10.1055/s-0038-1642057. Epub 2018 May 14.
6
Mohs micrographic surgery in the elderly: comparison of tumours, surgery and first-year follow-up in patients younger and older than 80 years old in REGESMOHS.老年患者的Mohs 显微外科手术:REGESMOHS 中年龄小于和大于 80 岁的患者的肿瘤、手术和第一年随访比较。
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):108-112. doi: 10.1111/jdv.14586. Epub 2017 Oct 5.
7
Mohs Micrographic Surgery for the Management of Cutaneous Malignancies.用于治疗皮肤恶性肿瘤的莫氏显微外科手术
Facial Plast Surg Clin North Am. 2017 Aug;25(3):291-301. doi: 10.1016/j.fsc.2017.03.002. Epub 2017 May 20.
8
Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.Mohs 显微外科治疗基底细胞癌:广泛亚临床扩散的适应证标准和预测因素评估。
Br J Dermatol. 2016 Apr;174(4):847-52. doi: 10.1111/bjd.14308. Epub 2016 Jan 28.
9
Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.基底细胞癌:发病机制、流行病学、临床特征、诊断、组织病理学及治疗
Yale J Biol Med. 2015 Jun 1;88(2):167-79. eCollection 2015 Jun.
10
Basal cell carcinoma: an evidence-based treatment update.基底细胞癌:基于证据的治疗更新。
Am J Clin Dermatol. 2014 Jul;15(3):197-216. doi: 10.1007/s40257-014-0070-z.